Potential use of WR6026 as prophylaxis against transfusion-transmitted American trypanosomiasis

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 613-615

  Chiari, Egler ^a   Oliveira, Alaide B ^a   Prado, Maria Auxiliadora F ^a   Alves, Ricardo J ^a   Galvão, Lucia M C ^a   Araujo, Fausto G ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b PALO ALTO MEDICAL FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITRYPANOSOMAL AGENT; CRYSTAL VIOLET; DIMETHYL SULFOXIDE; DYE; REAGENT; SITAMAQUINE; TC 199; TOLUENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TRANSFUSION; CHAGAS DISEASE; CONTROLLED STUDY; DISEASE TRANSMISSION; DOSE RESPONSE; MALE; MORTALITY; MOUSE; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

EID: 0029912275     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.613     Document Type: Article

References (32)

1. Araujo, F. G., J. Huskinson, and J. S. Remington. 1991. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob. Agents Chemother. 35:293-299.
2. Araujo, F. G., J. Huskinson-Mark, W. E. Gutteridge, and J. S. Remington. 1992. In vitro and in vivo activities of the hydroxynaphthoquinonc 566C80 against the cyst form of Toxoplasma gondii. Antimicrob. Agents Chemother. 36:326-330.
3. Berman, J. D., and L. S. Lee. 1983. Activity of 8-aminoquinolines against Leishmania tropica within human macrophages in vitro. Am J. Trop. Med. Hyg. 32:753-759.
4. Brener, Z., and E. Chiari. 1963. Vanaçöes morfológicas observadas em diferentes amostras de Trypanosoma cruzi. Rev. Inst. Med. Trop. Sao Paulo 5:220-224.
5. Camargo, E. P. 1964. Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media. Rev Inst. Med. Trop. Sao Paulo 6:93-100.
6. Camargo, M. E. 1966 Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test Rev. Inst Med. Trop. Sao Paulo 8:227-234.
7. Campbell, K. N., A. H. Sommers, J. F. Kerwin, and B. K. Campbell. 1946 Studies in quinoline series. III. Preparation of some 8-(ω-alkylamino-alkylamino)-quinolines J. Am. Chem. Soc. 68:1556-1559.
8. Carneiro, M., A. J. Romanha, and E. Chiari. 1991. Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes. Mem. Inst. Oswaldo Cruz 86:387-393.
9. Chang, H. R., and J. C. Pechère. 1988. Arteether, a qinghaosu derivative, in toxoplasmosis. Trans. R Soc. Trop. Med. Hyg. 82:867.
10. Chiari, E., A. B. Oliveira, D. S. Raslan, A. A. L. Mesquita, and K. G. Tavares. 1991. Screening in vitro of natural products against blood forms of Trypanosoma cruzi. Trans. R. Soc. Trop. Med. Hyg 85:372-374.
11. Croft, S. L., J. J. Walker, and W. E. Gutteridge. 1988. Screening of drugs for rapid activity against Trypanosoma cruzi trypomastigotes in vitro. Trop. Med Parasitol. 39:145-148.
12. Elderfield, R. C., H. E. Mertel, R. J. Mitch, I. M. Wempen, and E. Werble. 1955 Synthesis of primaquine and certain of its analogs. J. Am. Chem. Soc. 77:4816-4819.
13. Hawkins, D. R., T. Taylor, B. E. Patterson, and G. R. Morris. 1989. Bioavailability and pharmacokinetics of WR6026 2 HCl in beagle dogs. U.S. Army Medical Research and Development Command contract no. DAMD 17-87-C-7006. U.S Army Medical Research and Development Command. Washington, D.C.
14. Johnson, J. L., and L. M. Werbel. 1983. Synthesis and antileishmanial activity of 6-methoxy-4-methyl N-[6-(substituted-1-piperazinyl)]-8-quinolinamines and related compounds. J. Med. Chem. 26:189-194.
15. Kerndt, P. R., H. A. Waskin, L. V. Kirchhoff, F. Steurer, S. H. Waterman, J. M. Nelson, G. A. Gellert, and I. A. Shulman. 1991. Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California Transfusion 31:814-818.
16. Kinnamon, K. E., and E. A. Steck. 1977. In search of anti-Trypanosoma cruzi drugs: news leads from a mouse model. J. Med. Chem. 20:741-744.
17. Kinnamon, K. E., E. A. Steck, P. S. Loizeaux, W. L. Hanson, W. L. Chapman, Jr., and V. B. Waits. 1978 The antileishmanial activity of lepidines Am. J. Trop. Med Hyg. 27:751-757
18. Kirchhoff, L. V., A. A. Gam, and F. C. Gilliam. 1987. American trypanosomiasis (Chagas disease) in Central American immigrants Am. J Med. 82:915-920.
19. Klayman, D. L. 1985. Qinghaosu (artemisinin): an antimalarial from China. Science 228:1049-1055.
20. Marr, J. J. 1985 Antiparasitic agents, p. 286-301. In G. L Mandell, R. G. Douglas, and J. E. Bennett (ed.), Principles and practices of infectious diseases, 2nd ed John Wiley & Sons, Inc., New York.
21. Nussenzweig, V., R. Sonntag, A. Biancalana, J. L. P. Freitas, and V. Amato Neto. 1953 Açâo da violeta de genciana sobre oT. cruzi in vitro: sua importância na esterilização do sangue destinado à transfusāo. Rev. Paul. Med. 42:57-58.
22. Reba, R. C., K. G. Barry, and L. B. Altstatt. 1989. WR 6026 2HCl: short term dosage safety and tolerance study: single oral dose, rising dose levels. WR6026 IND Suppl 1. U.S. Army Medical Research and Development, Washington, D.C.
23. Report of the IT Annual Meeting about Applied Research on Chagas Disease. 1986 Conclusions of the working group "Transfusional Chagas disease." J. C. P. Dias coordinator. Rev Soc. Bras. Med. Trop 19:101-102.
24. Sherwood, J. A., G. S. Gachihi, R. K. Muigai, D. R. Skillman, M. Mugo, J. R. Rashid, K. M. A. Wasunna, J. B. O. Were, S. K. Kasili, J. M. Mbugua, G. Kirigi, K. U. Schaefer, C. N. Oster, L. L. Fleckenstein, J. D. Berman, T. G. Brewer, C. R. Roberts, A. J. Johnson, and B. G. Schuster. 1994 Phase 2 efficacy of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis. Clin. Infect Dis. 19:1034-1039
25. Silva, L H. P., and V. Nussenzweig. 1953. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clin. Biol. 20:391-208
26. Silveira, A. C., and D. F. Rezende. 1994. Epidemiologia e controle da transmissāo vetorial da doença de Chagas no Brasil Rev. Soc. Bras. Med. Trop. 27(Suppl III):11-22.
27. Skolnick, A. 1989. Does influx from endemic areas mean more transfusion associated Chagas disease? JAMA 15:1433.
28. Souza, H. M. 1989. The present state of chemoprophylaxis in transfusional Chagas' disease. Rev. Soc. Bras. Med. Trop. 22:1-3.
29. Theoharides, A. D., H. Chung, and H. Velazquez. 1985. Metabolism of a potential 8-aminoqumoline antileishmanial drug in rat liver microsomes. Biochem. Pharmacol. 34:181-188.
30. Wendel, S., and J. C. P. Dias. 1992 Transfusion transmitted Chagas disease, p 103-133 In S Wendel, Z. Brener, M. E. Camargo, and A. Rassi (ed.), Chagas disease (American trypanosomiasis). its impact on transfusion and clinical medicine, 1st ed International Society of Blood Transfusion. São Paulo, Brazil
31. Work, T. S. 1942. Antiplasmodial action and chemical constitution. VI Compounds related to lepylamme. J Chem. Soc. 1942:426-429
32. World Health Organization. 1991 Control of Chagas disease Report of a WHO Expert Committee WHO Technical Report Series 811. World Health Organization, Geneva.